Glycolipid replacement therapy for huntingtons disease

Ended Project Grant Awarded Last action

Award ID
R43NS080351
Recipient
Awarding agency
Obligated
$314,341

Award facts

Assistance listing
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
Completion date
Place of performance
Doylestown, PA 18901, USA

Award details come from USAspending.gov.

Quick answers

Who received award R43NS080351?

R43NS080351 was awarded to Seneb Biosciences Inc. by National Institutes of Health (Department of Health and Human Services) on July 15, 2012.

How much is award R43NS080351 worth?

$314,341 has been obligated on R43NS080351.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award